Latest KFF Health News Stories
When Temps Rise, So Do Medical Risks. Should Doctors and Nurses Talk More About Heat?
The medical dangers of heat are real. But people often ignore public heat alerts or don’t realize how vulnerable they are. A new alert system prompts clinicians to talk about heat with patients.
5 Things to Know About the New Drug Pricing Negotiations
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
Exclusive: CMS Study Sabotages Efforts to Bolster Nursing Home Staffing, Advocates Say
Research commissioned by the Centers for Medicare & Medicaid Services analyzed only staffing levels below what experts have previously called ideal. Patient advocates have been pushing for more staff to improve care.
She Paid Her Husband’s Hospital Bill. A Year After His Death, They Wanted More Money.
A widow encountered a perplexing reality in medical billing: Providers can come after patients to collect well after a bill has been paid.
California’s Medical Board Can’t Pay Its Bills, but Doctors Resist Proposed Fixes
Patient advocates have long alleged the Medical Board of California is ineffective at policing doctors. But a proposal to beef up its budget and overhaul procedures faces stiff resistance from the doctors’ lobby.
California Offers Lifeline to 17 Troubled Hospitals
California’s new lending program for distressed hospitals will provide Madera Community Hospital with interest-free loans of up to $52 million if it can agree on a viable reopening plan with Adventist Health. The state will offer an additional $240.5 million in interest-free loans to 16 other troubled hospitals.
Dangers and Deaths Around Black Pregnancies Seen as a ‘Completely Preventable’ Health Crisis
Studies show that high rates of Black fetal and infant deaths are largely preventable — and part of systemic failures that contribute to disproportionately high Black maternal mortality rates.
After Backlash, Feds Cancel Plan That Risked Limiting Breast Reconstruction Options
The Centers for Medicare & Medicaid Services backed off from a plan that could have curtailed access to a type of reconstructive surgery known as DIEP flap. Breast cancer patient advocates are relieved.
The Painful Pandemic Lessons Mandy Cohen Carries to the CDC
Mandy Cohen, the new director of the Centers for Disease Control and Prevention, earned praise for her leadership and communication as the face of North Carolina’s response to covid-19. People in the state’s most vulnerable communities tell a more complicated story.
Doctors and Patients Try to Shame Insurers Online to Reverse Prior Authorization Denials
Prior authorization is a common tool used by health insurers for many tests, procedures, and prescriptions. Frustrated by the process, patients and doctors have turned to social media to publicly shame insurance companies and elevate their denials for further review.
Tribal Health Workers Aren’t Paid Like Their Peers. See Why Nevada Changed That.
Community health workers, who often help patients get to their appointments and pick up prescriptions for them, have increasingly been recognized as an integral part of treating chronic illnesses. But state-run Medicaid programs don’t always reimburse them equally, usually excluding those who work on tribal lands.
The CDC Works to Overhaul Lab Operations After Covid Test Flop
In early 2020, U.S. public health labs received covid-19 tests from the Centers for Disease Control and Prevention that were flawed, as a result of poor design and contamination. Now the CDC is overhauling its lab operations, but efforts to be better prepared for future threats won’t be easy, observers say.
A Peek at Big Pharma’s Playbook That Leaves Many Americans Unable to Afford Their Drugs
Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development required to bring them to market nor their therapeutic value, recent research shows. Have drugmakers overplayed their hand?
Funyuns and Flu Shots? Gas Station Company Ventures Into Urgent Care
A Tulsa-based gas station chain is using its knowledge of how to serve customers and locate shops in easy-to-find spots to enter the urgent care industry, which has doubled in size over the past decade. Experts question how the explosion of convenient clinics will affect care costs and wait times.
Feds Say Hospitals That Redistribute Medicaid Money Violate Law
Federal officials are trying to clamp down on private arrangements among some hospitals to pay themselves back for the Medicaid taxes they’ve paid. State health officials and the influential hospital industry argue that regulators have no jurisdiction over the agreements.
North Carolina Hospitals Have Sued Thousands of Their Patients, a New Report Finds
An analysis of court records by the state treasurer and Duke researchers finds Atrium Health, originally a public hospital system, accounted for almost a third of the legal actions against North Carolina patients over roughly five years.
An Arm and a Leg: How a Surprise Bill Can Hitch a Ride to the Hospital
The No Surprises Act has helped rein in out-of-network medical bills, but ground ambulances are a costly exception. Hear why this service can still hit patients with big bills and what to do if you get one.
Promising Better, Cheaper Care, Kaiser Permanente’s National Expansion Faces Wide Skepticism
Kaiser Permanente, the California-based health care giant, is looking to dramatically expand its national presence. It’s committed $5 billion to a new unit called Risant Health and has agreed to acquire Pennsylvania-based Geisinger, but skeptics wonder how it will export its unique model to other states.
Proposed Rule Would Make Hospital Prices Even More Transparent
A Biden administration proposal would help standardize the data on prices that hospitals provide to patients, increase its usefulness to consumers, and boost enforcement. Previous rules gave hospitals too many loopholes.
Pruebas de sangre para detectar cáncer generan esperanza, pero también preocupación
Muchos expertos dicen que aún no está claro si las pruebas hacen más bien que mal, y que tener una ya disponible comercialmente les preocupa.
